Japanese Yen holds near one-month top vs weak USD as traders await Fed, BoJ meetings
The USD/JPY pair attracts fresh sellers following an uptick at the start of a new week, stalling Friday's modest bounce from the vicinity of the 156.00 mark, or its lowest level since September 18. Spot prices seem vulnerable below the 157.00 mark, though bears might refrain from placing aggressive bets ahead of this week's key central bank events and data risks.
The US Federal Reserve (Fed) is scheduled to announce its decision at the end of a two-day policy meeting on Wednesday. The focus, however, will be on the accompanying rate statement and Fed Chair Kevin Warsh's comments during the post-meeting press conference. Apart from this, important US macro releases – the Advance Q3 GDP print and the Personal Consumption Expenditures (PCE) Price Index on Thursday – will influence market expectations about the Fed's future policy path and drive the US Dollar (USD). The market focus would then shift to the crucial Bank of Japan (BoJ) policy update on Friday, which should further determine the near-term trajectory for the USD/JPY pair.
In the meantime, Fed officials recently signaled that there is no urgency to raise interest rates at the upcoming policy meeting. Furthermore, the recent fall in US bond yields from multi-year highs keeps a lid on the attempted USD recovery from a three-week low, touched last Thursday. The Japanese Yen (JPY), on the other hand, draws support from BoJ Governor Kazuo Ueda's more hawkish comments last week, indicating that underlying inflation is nearing the 2% target, which strengthens the case for an imminent interest rate hike. This, in turn, might continue to act as a tailwind for the USD/JPY pair, though persistent geopolitical uncertainties could limit deeper losses for the safe-haven buck.
In the latest developments surrounding the Middle East crisis, US President Donald Trump has ruled out immediate military action against Iran. However, the Iran-backed Houthis in Yemen threatened on Sunday that they will keep attacking Saudi Arabia's King Khalid Airport in Riyadh. This comes on top of stalled US-Iran talks and keeps the geopolitical risk premium firmly in play. Apart from this, traders are still pricing in around an 80% chance that the US Fed will raise borrowing costs again in December. This, in turn, might hold back USD bears from placing aggressive bets and help limit the downside for the USD/JPY pair, warranting caution before positioning for any further downside.
USD/JPY 4-hour chart
Technical Analysis
The USD/JPY pair keeps a bearish near-term tone below the 200-period Simple Moving Average (SMA) on the 4-hour chart. The said barrier is pegged at 157.14 and is followed by the 23.6% Fibonacci retracement at 157.58. Only a sustained break above this band would reopen the path toward the recent cycle highs.
On the downside, immediate support aligns with the 38.2% retracement at 156.69, ahead of a deeper Fibonacci cluster at 155.98 and 155.26 (50% and 61.8%), where buyers may attempt to stabilize the pullback.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Earnings Preview | After a 30% Drop in Stock Price, Will HBM4 Mass Production and DRAM Price Increases Reignite SK Hynix (SKHY.US) Rally?
SK Hynix will announce its financial results for the third quarter of fiscal year 2026 on October 28.
Cyclical stocks always peak when they're “cheapest” — Citrini, the “chip influencer” who was the earliest to be bullish on AI hardware, is now quietly exiting
Citrini, once the most prominent bull in AI hardware, has now significantly reduced his semiconductor holdings and currently holds some short positions. He believes that the financing structure for AI infrastructure has shifted from tech giants' own cash flows to equity and debt markets, and that sentiment alone could sever the funding chain and impact fundamentals. Strategically, he is long Meta and short Google. Citrini also asserts that the bottleneck in AI pharmaceutical development is not computational power, but rather a "lack of monkeys."
New Zealand Dollar gains ground to near 0.5700 as RBNZ rate hike bets rise
Median survival prolonged by 5.7 months! Roche (RHHBY.US) lung cancer new drug wins in head-to-head trial, major catalyst for oncology business
Roche's investigational lung cancer drug divarasib extended patient survival by nearly six months compared to competing therapies in a late-stage clinical trial, promising to further strengthen the Swiss pharmaceutical company's oncology portfolio.
Crypto prices
More
